Ochsner Health COVID-19 SharePoint Site "Safety On Site" Click here to enter an S.O.S.
Medications listed are available on OH EPIC Formulary, unless otherwise noted.
Not all formulary medications are available at each facility. Please refer to your local pharmacy for available inventory.
Search results for:

secukinumab

secukinumab
Drug Name Form Strength Infusion Center Available Restricted Non-formulary Ambulatory Available Interchange REMS
Cosentyx SOLUTION, SUBCUTANEOUS 150 mg/mL        


Additional Information and Links

OH Epic Formulary, available via therapy plan, restricted to:

  • Indication: psoriatic arthritis, active ankylosing spondylitis, or non-radiographic axial spondylarthritis
  • Service line: Rheumatology
  • Formulary location: Outpatient Infusion
  • Service location: Outpatient Infusion, Home Infusion
  • Patient population: Adult
  • Prior authorization required: Yes
  • Restriction/criteria of use (all will apply unless specified):
    • No active tuberculosis (TB), Hepatitis B, or Hepatitis C infection-screening is required prior to initiating and during therapy
    • No known active infection
    • Patient is not on concurrent treatment with another IL-inhibitor, TNF-inhibitor, biologic response modifier or other non-biologic immunomodulating agent (e.g., abrocitinib, tofacitinib, baricitinib, upadacitinib, deucravacitinib, etc.)
      • Use with DMARDs and PDE inhibitor (apremilast) is allowable
    • Patient must not have had previous cell depleting therapy (anti-thymoglobulin, alemtuzumab, etc.) within past month
      • Psoriasis Arthritis (PsA)
        • Diagnosis of Psoriasis Arthritis (PsA)
        • For patients with predominantly axial disease, a trial and failure of ONE non-steroidal anti- inflammatory agent (NSAID), unless use is contraindicated.

OR

        • For patients with peripheral arthritis, a trial and failure of ONE oral disease-modifying anti rheumatic agent (DMARD) such as methotrexate, azathioprine, sulfasalazine, or hydroxychloroquine, etc., unless use is contraindicated.
      • Ankylosing spondylitis (AS)
        • Diagnosed with active ankylosing spondylitis (AS)
        • Patient had an adequate trial and failure of at least TWO (2) non-steroidal anti-inflammatory agents (NSAIDs), unless use is contraindicated
      • Non-radiographic Axial Spondylarthritis
        • Diagnosed with active axial spondylarthritis
        • Patient had an adequate trial and failure of at least TWO (2) non-steroidal anti-inflammatory agents (NSAIDs) unless use is contraindicated

 


Last updated: Nov. 18, 2024


This site is intended for the staff of Ochsner Health. While others may view accessible pages, Ochsner Health makes no warranty, express or implied, as to the use of this information outside of Ochsner Health.